Resumen de acción MED
Medifast, Inc. a través de sus filiales, se dedica a la fabricación y venta de productos para adelgazar, control de peso y vida sana en Estados Unidos y Asia-Pacífico.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Medifast, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$26.69 |
| 52 Week High | US$109.52 |
| 52 Week Low | US$25.36 |
| Beta | 1.15 |
| 1 Month Change | -18.70% |
| 3 Month Change | -50.45% |
| 1 Year Change | -70.23% |
| 3 Year Change | -90.95% |
| 5 Year Change | -80.62% |
| Change since IPO | 385.27% |
Noticias y actualizaciones recientes
Medifast's (NYSE:MED) Conservative Accounting Might Explain Soft Earnings
May 06
The Returns On Capital At Medifast (NYSE:MED) Don't Inspire Confidence
May 01Recent updates
Medifast's (NYSE:MED) Conservative Accounting Might Explain Soft Earnings
May 06The Returns On Capital At Medifast (NYSE:MED) Don't Inspire Confidence
May 01Medifast: Cheap Valuation, Uncertain Future
Mar 20Medifast Is Getting Attractive
Mar 07Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings
Feb 22Medifast Share Price Loses Weight, But Is There Still Value To Be Had?
Jan 20Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?
Dec 09Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome
Nov 24Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?
Nov 21Medifast: Unveiling A Challenge Beyond Weight Loss Drugs
Nov 09Medifast: The Race To Weight-Loss Drugs Not Lost Yet
Oct 09Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs
Aug 04Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?
Jul 26In The Murky MLM Space, Medifast Might Actually Hold Some Promise
Jul 21Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)
Jul 05Medifast: In Survival Mode Against Diet Pills And The Recession
Jun 14Medifast Holds Value During Headwinds
May 28Medifast Non-GAAP EPS of $3.70 beats by $1.48, revenue of $337.2M beats by $7.1M
Feb 21Medifast: A Low Earnings Multiple Despite Strong Financial Performance
Feb 07At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?
Jan 19Medifast declares $1.64 dividend
Dec 08A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)
Dec 01Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 10One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates
Nov 08Medifast: This High-Yield Blue Chip Dividend Stock Is A Strong Buy
Nov 06What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?
Oct 20We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt
Sep 18Medifast declares $1.64 dividend
Sep 08Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?
Sep 02Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good
Aug 21Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year
Aug 09Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?
Jul 27What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?
Jul 12Medifast And Its Real Value
Jun 24Medifast: Growth And Value At A Reasonable Price
May 17Here's Why I Think Medifast (NYSE:MED) Might Deserve Your Attention Today
May 03Rentabilidad de los accionistas
| MED | US Personal Products | Mercado US | |
|---|---|---|---|
| 7D | -24.8% | -4.0% | 0.6% |
| 1Y | -70.2% | -25.4% | 23.9% |
Rentabilidad vs. Industria: MED obtuvo unos resultados inferiores a los del sector US Personal Products , que el año pasado arrojó un rendimiento del -28%.
Rentabilidad vs. Mercado: MED obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| MED volatility | |
|---|---|
| MED Average Weekly Movement | 10.0% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de MED ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de MED (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1980 | 634 | Dan Chard | medifastinc.com |
Medifast, Inc. a través de sus filiales, se dedica a la fabricación y venta de productos para adelgazar, control de peso y vida sana en Estados Unidos y Asia-Pacífico. Ofrece barritas, bocadillos, cereales, cereales crujientes, bebidas, platos fuertes, avena, tortitas, pudding, helados, batidos, smoothies, pasteles suaves y sopas bajo las marcas OPTAVIA, OPTAVIA ACTIVE y Optimal Health. La empresa comercializa sus productos a través de transacciones en el punto de venta, así como a través de la plataforma de comercio electrónico.
Resumen de fundamentos de Medifast, Inc.
| Estadísticas fundamentales de MED | |
|---|---|
| Capitalización bursátil | US$285.46m |
| Beneficios(TTM) | US$67.76m |
| Ingresos (TTM) | US$897.81m |
4.2x
Ratio precio-beneficio (PE)0.3x
Ratio precio-ventas (PS)¿Está MED sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MED | |
|---|---|
| Ingresos | US$897.81m |
| Coste de los ingresos | US$241.06m |
| Beneficio bruto | US$656.75m |
| Otros gastos | US$588.99m |
| Beneficios | US$67.76m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 6.34 |
| Margen bruto | 73.15% |
| Margen de beneficio neto | 7.55% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado MED a largo plazo?
Ver rendimiento histórico y comparativa